Revolutionizing Drug Invention

Applied BioMath was founded in 2013 by Dr. John Burke, Dr. Joshua Apgar, and Andrew Sutherland to help transform both the quality and economics of drug invention. Dr. Burke and Dr. Apgar have been leaders in the biological engineering field for decades beginning with their research at MIT and continuing with their many roles in top pharmaceutical and biotechnology companies. They, along with Andrew Sutherland, have built an innovative, experienced, and passionate team of mathematicians, biologists, clinical pharmacologists and pharmaceutical industry experts who leverage biology, proprietary technology, high-performance computing (HPC), and decades of industry experience. Applied BioMath's services are used worldwide by pharmaceutical and biotechnology companies to better understand the desired target product profile for an indication of interest, determine best-in-class properties of a clinical candidate, and identify key differentiators from competitors.